November 01, 2017
1 min watch

VIDEO: FDA panel gives overwhelming support to Rhopressa approval

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

NEWPORT BEACH, Calif. — At the OCTANe Medical Technology Innovation Forum here, Tom Mitro, chief operating officer of Aerie Pharmaceuticals, discusses the recent FDA panel on Rhopressa for the treatment of glaucoma.